Zobrazeno 1 - 10
of 856
pro vyhledávání: '"W Sieghart"'
Autor:
Robert Eferl, Gerald Timelthaler, Matthias Pinter, Merima Herac, Markus Peck-Radosavljevic, Kaoru Tsuchiya, Nataliya Rohr-Udilova, Michael Trauner, Katharina Wöran, Tobias Meischl, W. Sieghart, Judith Stift, Martina Salzmann, Erika Jensen-Jarolim, Rolf Schulte-Hermann
Publikováno v:
Hepatology Communications, Vol 5, Iss 11, Pp 1939-1952 (2021)
Hepatology Communications
Hepatology Communications
Tumor‐infiltrating immune cells are relevant prognostic and immunotherapeutic targets in hepatocellular carcinoma (HCC). Mast cells play a key role in allergic response but may also be involved in anticancer immunity. Digital morphometric analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d6d7908abbde7b8d6f85547f6eb79c
https://doaj.org/article/ceaff1a6e20a482590cea1ba21b153d3
https://doaj.org/article/ceaff1a6e20a482590cea1ba21b153d3
Autor:
Davide Pastorelli, Maria Reig, Vincenzo Mazzaferro, Nevena Damjanov, Marie Dupuy, Eric Assenat, Dale Shuster, Lorenza Rimassa, Terri Goldberg, Markus Peck-Radosavljevic, Vittorina Zagonel, Armando Santoro, Brian Schwartz, William P. Harris, Nicola Personeni, Francesca Negri, Philippe Mathurin, W. Sieghart, Thomas Decaens, Jennifer J. Knox, Giovanni Abbadessa, Jordi Bruix, Elena Rota Caremoli, Bruno Daniele, Camillo Porta, Maria Lamar, Luigi Bolondi, Carlos López López, Marc Pracht, Jörg Trojan
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2018, 19 (5), pp.682--693. ⟨10.1016/S1470-2045(18)30146-3⟩
Ann Transl Med
Lancet Oncology, Elsevier, 2018, 19 (5), pp.682--693. ⟨10.1016/S1470-2045(18)30146-3⟩
Ann Transl Med
International audience; BACKGROUND: Tivantinib (ARQ 197), a selective, oral MET inhibitor, improved overall survival and progression-free survival compared with placebo in a randomised phase 2 study in patients with high MET expression (MET-high) hep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0acc879b38e69d9151f70be7080f1425
https://doi.org/10.1016/s1470-2045(18)30146-3
https://doi.org/10.1016/s1470-2045(18)30146-3
Autor:
Barbara Tribl, M. Trauner, M Schoeniger-Hekele, Werner Dolak, W Sieghart, Y Kamogawa-Schifter
Publikováno v:
Zeitschrift für Gastroenterologie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99eaf68a7b1cb11a1a9f72fd79a50bc5
https://doi.org/10.1055/s-0039-1691879
https://doi.org/10.1055/s-0039-1691879
Autor:
B Datz, W. Sieghart, M Trauner, T Kudlich, A Geier, L Kern, Ingo Klein, Matthias Pinter, M Rau, Johannes M. Weiss, Oliver Götze
Publikováno v:
Information und Programm: www.gfgb.org.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d157a3c33d23666d98d0f858553bb537
https://doi.org/10.1055/s-0038-1648600
https://doi.org/10.1055/s-0038-1648600
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L. Zell, Markus Peck-Radosavljevic, Gerald Timelthaler, Christine Haider, Markus Grubinger, Wolfgang Mikulits, W. Sieghart, Cédric Coulouarn, H. Heidemarie, H. Julia, W. Roland, K. Schlangen
Publikováno v:
Journal of Hepatology. 68:S674-S675
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::020f8dbc26f910f3d44916f2e6f5e156
https://doi.org/10.1016/s0168-8278(18)31607-6
https://doi.org/10.1016/s0168-8278(18)31607-6
Autor:
Nataliya Rohr-Udilova, Thomas Reiberger, Arnulf Ferlitsch, Markus Peck-Radosavljevic, Matthias Pinter, W. Sieghart
Publikováno v:
Alimentary Pharmacology & Therapeutics. 35:83-91
Aliment Pharmacol Ther 2012; 35: 83–91 Summary Background Increased intrahepatic vascular resistance and hyperperfusion in the splanchnic circulation are the principal mechanisms leading to portal hypertension in cirrhosis. Several preclinical stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::674de73d045a98ced04590ae451ff30d
https://doi.org/10.1111/j.1365-2036.2011.04896.x
https://doi.org/10.1111/j.1365-2036.2011.04896.x
Autor:
Wolfgang Vogel, Christian Müller, Ivo Graziadei, Robert Königsberg, Maximilian Schöniger-Hekele, B. Grünberger, Matthias Pinter, R Buder, W. Sieghart, Rudolf E. Stauber, Andreas Maieron, A. Weissmann, F Hucke, G. Kornek, Markus Peck-Radosavljevic, J. Matejka
Publikováno v:
Alimentary Pharmacology & Therapeutics. 34:949-959
BACKGROUND Sorafenib is the new reference standard for patients with advanced hepatocellular carcinoma (HCC). AIM To identify prognostic factors in sorafenib-treated HCC patients and to evaluate outcomes with respect to liver function. METHODS In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5be400e9125bfd0ba2db9ed98382cada
https://doi.org/10.1111/j.1365-2036.2011.04823.x
https://doi.org/10.1111/j.1365-2036.2011.04823.x
Autor:
Markus Peck, Nataliya Rohr-Udilova, W. Sieghart, Christian Müller, F. Hucke, M. Trauner, S Popp, Bernhard Scheiner, Matthias Pinter, Thomas Reiberger, Simona Bota
Publikováno v:
Journal of Hepatology. 68:S429
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d4c1508c98ff5d711b6d6a2f7924adb
https://doi.org/10.1016/s0168-8278(18)31098-5
https://doi.org/10.1016/s0168-8278(18)31098-5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.